Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Ropidoxuridine is a radiosensitizer and a prodrug form of the antiviral compound idoxuridine (Item No. 20222).1 It also inhibits viral plaque formation in HeLa cells infected by herpes simplex virus 1 (HSV-1) or HSV-2 when used at a concentration of 100 µM.2 Ropidoxuridine (1,000 mg/kg per day for six days) enhances radiation-induced decreases in tumor growth without reducing body weight in an HT-29 colon cancer mouse xenograft model.1 It increases animal survival in a mouse model of lethal HSV-2 infection when administered at a dose of 100 mg/kg every five days.2
WARNING This product is not for human or veterinary use.
1. Preclinical evaluation of 5-
2. Anti-